Kurma Keerthi, Alix-Panabières Catherine
Laboratory of Rare Human Circulating Cells (LCCRH), University Medical Centre of Montpellier, Montpellier, France.
CREEC/CANECEV, MIVEGEC (CREES), University of Montpellier, CNRS, IRD, Montpellier, France.
Front Cell Dev Biol. 2023 May 5;11:1188499. doi: 10.3389/fcell.2023.1188499. eCollection 2023.
Metastatic progression is the deadliest feature of cancer. Cancer cell growth, invasion, intravasation, circulation, arrest/adhesion and extravasation require specific mechanical properties to allow cell survival and the completion of the metastatic cascade. Circulating tumor cells (CTCs) come into contact with the capillary bed during extravasation/intravasation at the beginning of the metastatic cascade. However, CTC mechanobiology and survival strategies in the bloodstream, and specifically in the microcirculation, are not well known. A fraction of CTCs can extravasate and colonize distant areas despite the biomechanical constriction forces that are exerted by the microcirculation and that strongly decrease tumor cell survival. Furthermore, accumulating evidence shows that several CTC adaptations, via molecular factors and interactions with blood components (e.g., immune cells and platelets inside capillaries), may promote metastasis formation. To better understand CTC journey in the microcirculation as part of the metastatic cascade, we reviewed how CTC mechanobiology and interaction with other cell types in the bloodstream help them to survive the harsh conditions in the circulatory system and to metastasize in distant organs.
转移进展是癌症最致命的特征。癌细胞的生长、侵袭、内渗、循环、滞留/黏附和外渗需要特定的力学特性,以确保细胞存活并完成转移级联反应。在转移级联反应开始时,循环肿瘤细胞(CTC)在通过毛细血管床时会经历外渗/内渗过程。然而,CTC在血液中,特别是在微循环中的力学生物学和生存策略尚不清楚。尽管微循环施加的生物力学收缩力会显著降低肿瘤细胞的存活率,但仍有一部分CTC能够外渗并在远处定植。此外,越来越多的证据表明,一些CTC通过分子因子以及与血液成分(如毛细血管内的免疫细胞和血小板)的相互作用而发生的适应性变化,可能会促进转移灶的形成。为了更好地理解作为转移级联反应一部分的CTC在微循环中的行程,我们综述了CTC的力学生物学以及它与血液中其他细胞类型的相互作用如何帮助它们在循环系统的恶劣条件下存活并转移至远处器官。
Cancer Metastasis Rev. 2024-12
Biomed Pharmacother. 2024-11
Front Med (Lausanne). 2018-2-19
Nat Rev Dis Primers. 2025-8-21
Cells. 2025-7-16
J Natl Cancer Cent. 2021-12-4
Med Rev (2021). 2022-4-26
Front Bioeng Biotechnol. 2022-5-12
APL Bioeng. 2022-2-1
Signal Transduct Target Ther. 2021-11-22
Vasc Biol. 2021-9-14
Cancers (Basel). 2021-7-22